The Allstate
ALLNYSEUSD
- Source valuation snapshot. Not a live recalculation.
- Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
- Diluted earnings per share from the latest filed annual.
- $261.12 Prior regular-session close from the quote source.
- $256.86–$262.35 Regular-session low and high so far today.
- 1.1M Regular-session shares traded · Nov 11, 4:00 PM ET.
- Not yet confirmed The company has not confirmed its next report date. Reported quarters are available in the chart’s Earnings view.
- $191.13–$281.11 52-week trading low and high returned by the quote source.
Understand the Business
Why the Stock Moved
Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.
The core investment thesis
Own ALL if Allstate can compound shareholder value by converting pricing leverage and underwriting discipline in personal P&C lines into predictable underwriting profits and strong operating cash flow, then deploying the resulting capital (higher equity and cash.
ALL price history
Loading recent earnings…
Investment thesis
What must happen next
Allstate's pricing discipline and reserve management will keep underwriting results profitable enough to sustain the recent jump in net income and convert premium growth into durable profits.StrengtheningMateriality: High
Net income swung from -$0.188B in 2023 to $4.667B in 2024 and $10.282B in 2025, consistent with a major improvement in underwriting/investment results. If underwriting stays disciplined, Allstate will continue generating large, repeatable net income and cash flow that supports capital returns and valuation; if it doesn't, earnings and capital returns will be volatile and the stock will re-rate.
Watch: A repeat of a large catastrophe year (e.g., hurricane/catastrophe season materially above historical averages) that materially increases claims frequency/severity and drives adverse reserve development.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Net income swung from -$0.188B in 2023 to $4.667B in 2024 and $10.282B in 2025, consistent with a major improvement.
Open source ↗Allstate will continue converting underwriting and investment activities into strong operating cash flow that funds capital returns and strengthens the balance sheet.StrengtheningMateriality: High
Operating cash flow rose from $4.228B in 2023 to $8.931B in 2024 and $10.11B in 2025, showing materially stronger cash generation. High, stable operating cash flow is how insurers fund buybacks, dividends and reinsurance without jeopardizing solvency; sustained cash conversion supports per-share value even if ROE fluctuates.
Watch: Sharp, sustained investment portfolio losses or lower investment spreads that reduce cash and underwriting-related cash receipts.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Operating cash flow rose from $4.228B in 2023 to $8.931B in 2024 and $10.11B in 2025, showing materially stronger cash.
Open source ↗Rising equity and asset base gives Allstate the capital to buy reinsurance, sustain capacity through catastrophe cycles, and return excess capital to shareholders without forcing dilutive financing.HoldingMateriality: Medium
Stockholders' equity expanded from $17.77B in 2023 to $21.442B in 2024 and $30.61B in 2025. If capital remains ample, the company can smooth underwriting volatility and fund buybacks/dividends that increase per-share value; if capital erodes, management must conserve cash and shareholder returns fall.
Watch: Large unexpected reserve strengthening or catastrophe losses that materially reduce equity and force capital raises or cutbacks in shareholder distributions.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Stockholders' equity expanded from $17.77B in 2023 to $21.442B in 2024 and $30.61B in 2025.
Open source ↗Allstate's scale in personal lines will continue to drive revenue growth (premiums written and earned), giving it the pricing leverage to raise rates when loss costs rise and spread fixed costs.StrengtheningMateriality: Medium
Revenue increased from $50.60B (2021) to $67.685B (2025), showing multi-year top-line growth. Sustained premium growth preserves underwriting leverage and amortizes fixed operating costs; if scale erodes, margin pressure follows and per-share earnings stagnate.
Watch: Market share loss to lower-cost direct insurers or insurtech entrants reducing premium volume and forcing Allstate to lower rates.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Revenue increased from $50.60B (2021) to $67.685B (2025), showing multi-year top-line growth.
Open source ↗
Full investment case & evidence
Loading the original research archive…
Original research
Allstate's pricing discipline and reserve management will keep underwriting results profitable enough to sustain the recent jump in net income and convert premium growth into durable profits. If underwriting stays disciplined, Allstate will continue generating large, repeatable net income and cash flow that supports capital returns and valuation; if it doesn't, earnings and capital returns will be volatile and the stock will re-rate.
Allstate will continue converting underwriting and investment activities into strong operating cash flow that funds capital returns and strengthens the balance sheet. High, stable operating cash flow is how insurers fund buybacks, dividends and reinsurance without jeopardizing solvency; sustained cash conversion supports per-share value even if ROE fluctuates.
Rising equity and asset base gives Allstate the capital to buy reinsurance, sustain capacity through catastrophe cycles, and return excess capital to shareholders without forcing dilutive financing. If capital remains ample, the company can smooth underwriting volatility and fund buybacks/dividends that increase per-share value; if capital erodes, management must conserve cash and shareholder returns fall.
Allstate's scale in personal lines will continue to drive revenue growth (premiums written and earned), giving it the pricing leverage to raise rates when loss costs rise and spread fixed costs. Sustained premium growth preserves underwriting leverage and amortizes fixed operating costs; if scale erodes, margin pressure follows and per-share earnings stagnate.
All standing thesis claims
Original report summary
Allstate can compound shareholder value by converting pricing leverage and underwriting discipline in personal P&C lines into predictable underwriting profits and strong operating cash flow, then deploying the resulting capital (higher equity and cash.
Bull case and bear case
Bull case and bear case for Allstate
Where the evidence on Allstate stands: Holding on the latest evidence (Oct 19, 2026). Of its 4 thesis points, 3 strengthening and 1 holding.
Bull case: what the evidence supports
Allstate's pricing discipline and reserve management will keep underwriting results profitable enough to sustain the recent jump in net income and convert premium growth into durable profits.
Allstate will continue converting underwriting and investment activities into strong operating cash flow that funds capital returns and strengthens the balance sheet.
Rising equity and asset base gives Allstate the capital to buy reinsurance, sustain capacity through catastrophe cycles, and return excess capital to shareholders without forcing dilutive financing.
Allstate's scale in personal lines will continue to drive revenue growth (premiums written and earned), giving it the pricing leverage to raise rates when loss costs rise and spread fixed costs.
Bear case: what would count against it
A repeat of a large catastrophe year (e.g., hurricane/catastrophe season materially above historical averages) that materially increases claims frequency/severity and drives adverse reserve development.
Sharp, sustained investment portfolio losses or lower investment spreads that reduce cash and underwriting-related cash receipts.
Large unexpected reserve strengthening or catastrophe losses that materially reduce equity and force capital raises or cutbacks in shareholder distributions.
Thesis-Break Engine
What has broken in Allstate’s thesis
Each break OptimistFi flagged on Allstate, dated — with what has historically followed the same kind of break across the market, not a forecast for Allstate.
- Price target fell below the stockcondition set before this filing
Across all companies, this kind of break has happened 1,809 times before. Those stocks trailed comparable companies by a median of 1% over the next six months, and 33% of them trailed it by 10 points or more.
MARKET + FINANCIAL SNAPSHOT
The numbers behind the thesis
What Changed
- MixedRegulation FD disclosure.
Allstate filed an SEC 8-K on 2026-10-15: Regulation FD disclosure. It is a dated development that tests the current thesis.
- MixedRegulation FD disclosure.
Allstate filed an SEC 8-K on 2026-09-17: Regulation FD disclosure. It is a dated development that tests the current thesis.
- MixedRegulation FD disclosure.
Allstate filed an SEC 8-K on 2026-08-20: Regulation FD disclosure. It is a dated development that tests the current thesis.
Risks / falsifiers
What could break the thesis
- A repeat of a large catastrophe year (e.g., hurricane/catastrophe season materially above historical averages) that materially increases claims frequency/severity and drives adverse reserve development.
- Sharp, sustained investment portfolio losses or lower investment spreads that reduce cash and underwriting-related cash receipts.
- Large unexpected reserve strengthening or catastrophe losses that materially reduce equity and force capital raises or cutbacks in shareholder distributions.
- Market share loss to lower-cost direct insurers or insurtech entrants reducing premium volume and forcing Allstate to lower rates.
ALL news
Loading headlines…
Financial statements
ALL income statement
Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.
ALL: quick answers
- Have members of Congress traded ALL?
- Reports made public in the last 90 days disclose 3 trades in ALL by 2 filers: 1 purchase and 2 sales. They are filed under the STOCK Act by members of Congress, the President and senior officials. Every disclosed ALL trade
- Which well-known investors own ALL?
- 2 of the 37 well-known funds tracked here reported ALL shares in their latest 13F filings. By share of the fund's portfolio: Markel Group (Tom Gayner), 0.3%; Bridgewater Associates (Ray Dalio), 0.1%. Fund portfolios
ALL in well-known investors’ portfolios
2 of 37 funds reported ALL shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.
| Fund | Of its portfolio | Value | Change | Quarter |
|---|---|---|---|---|
| Tom GaynerMarkel Group | 0.27% | $34.3M | No change | Q3 2026 |
| Ray DalioBridgewater Associates | 0.05% | $13.4M | −72.9% | Q2 2026 |
